NCT00111982View on ClinicalTrials.gov

Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

February 28, 2006

Conditions
Parkinson's Disease
Interventions
BIOLOGICAL

Liatermin

Liatermin

Sponsors

Lead Sponsor

Amgen

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Amgen

INDUSTRY

NCT00111982 - Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin | Biotech Hunter | Biotech Hunter